Literature DB >> 33654861

Immunohistochemical Staining of CD8α in Diabetic Mouse Kidney.

Ming-Zhi Zhang1,2, Raymond C Harris1,2,2.   

Abstract

Immune cell infiltration, particularly cytotoxic CD8α lymphocyte infiltration, plays an important role in development of diabetic nephropathy. Although CD8α infiltration can be evaluated by its production of cytokines, its localization in the kidney is of particular importance. The current protocol describes CD8α immunostaining using a Vectastain ABC kit. This protocol works well with most commercially available antibodies, including CD8α antibodies in kidneys of diabetic mice.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  ABC kit; Biotinylated secondary antibody; CD8α lymphocyte; Diabetic nephropathy; Immunostaining

Year:  2019        PMID: 33654861      PMCID: PMC7854133          DOI: 10.21769/BioProtoc.3364

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  4 in total

1.  Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.

Authors:  Zhilian Li; Yan Li; Jessica M Overstreet; Sungjin Chung; Aolei Niu; Xiaofeng Fan; Suwan Wang; Yinqiu Wang; Ming-Zhi Zhang; Raymond C Harris
Journal:  Diabetes       Date:  2018-06-29       Impact factor: 9.461

2.  Cyclooxygenase-2 in rat nephron development.

Authors:  M Z Zhang; J L Wang; H F Cheng; R C Harris; J A McKanna
Journal:  Am J Physiol       Date:  1997-12

3.  Immunohistochemical localization of lipocortin 1 in rat brain is sensitive to pH, freezing, and dehydration.

Authors:  J A McKanna; M Z Zhang
Journal:  J Histochem Cytochem       Date:  1997-04       Impact factor: 2.479

4.  Renal Medullary Interstitial COX-2 (Cyclooxygenase-2) Is Essential in Preventing Salt-Sensitive Hypertension and Maintaining Renal Inner Medulla/Papilla Structural Integrity.

Authors:  Ming-Zhi Zhang; Suwan Wang; Yinqiu Wang; Yahua Zhang; Chuan Ming Hao; Raymond C Harris
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.